RYAN COHEN becomes a shareholder of NORDSTROM
According to a report released by Reuters, Ryan Cohen is increasing its stake in Nordstrom to force the American department store to change its board members and improve its performance.
Ryan Cohen, a billionaire investor, hopes to replace at least one director.
Nordstrom, a struggling luxury goods retailer, has underperformed its peers, and Ryan Cohen hopes to force the "unqualified" director to leave to help the struggling department store turn losses into profits. Ryan Cohen's move undoubtedly encouraged investors, with Nordstrom's stock price rising by about 25% at the close of last week.
The Wall Street Journal reported that Ryan Cohen had previously traveled to Seattle, where Nordstrom is located, to meet with family members and learn more about the business.
Ryan Cohen and Nordstrom did not immediately respond to Reuters' request for comment.
Last September, this department store chain implemented a "poison pill" measure to prevent investors from increasing their holdings by 10% or more, after Mexican department store Liverpool disclosed a 9.9% passive stake in Nordstrom.
Ryan Cohen also owns a 9.8% stake in Bed Bath&Beyond, and he sold the company in August, when the stock experienced an astonishing rebound. According to Reuters' review of regulatory documents and an insider, he will receive a pre tax profit of $55 million to $60 million in this sale.
Ryan Cohen, known for helping ignite big rallies in so-called meme stocks including GameStop Corp., GME -0.91%decrease; red down pointing triangle is one of the top-five nonfamily shareholders of Nordstrom, the people said.
KAO FOUNDS KEY REASON ON CAUSE OF FRIZZ
2026-07-26
Trade Alert
Delivering the latest product trends and industry news straight to your inbox.
(We'll never share your email address with a third-party.)
Related News
-
Laboratoire PYC showcases its collagen-driven nutricosmetic innovations
-
Kemira to Acquire SIDRA Wasserchemie, Expanding European Water Treatment Footprint
-
The Last 10% Tariff Trap: A New Chapter in U.S.–China Negotiations on “Fentanyl Tariffs”
-
Amazon Turns Lilly’s Weight-Loss Pill Into a Retail Logistics Play
-
Axplora Expands Indian Market: €6.5 Million to Expand API Manufacturing in Vizag
-
DKSH Upgrades its Malaysia Innovation Center to Strengthen Technical Service Capabilities for the Southeast Asian Market
-
Lilly Bets Bigger on China
-
Rising API Costs Threaten Drug Prices
-
New Titanium Dioxide Alternative Moves Closer to Market
-
China Suspends Sulfuric Acid Exports, Global Copper and Fertilizer Supply Under Strain
Recommend Reading
-
From Painting Walls to Total Collapse: The RMB 152 Million Debt That Tore Off the Last Veil of Asia Chuangneng’s Paint Empire
-
Selling the Family Silver for a New Suit? Why Bohai Chemical’s Transformation Drama Got Canceled After Just Two Acts
-
Pfizer Warns Germany Over Drug-Pricing Policy
-
India Raises Cancer Drug Price Caps by 50%
-
New York Targets Additives and GRAS Disclosure
-
U.S.-Iran Negotiations Make Progress, Dragging Oil Prices Down by Over 3%; Market May Remain Volatile in the Coming Period
-
Methanol Market Conditions Consolidate and Operate
-
Permanganate: Properties, Uses, and Safety
-
China’s EVA Market Has Entered a Downward Trend Since May
-
ICIS Global No.58: ECHEMI Again Ranks Among the World’s Chemical Distributors